A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers

Clinical trial NCT00513565 · COMPLETED

Trial details

NCT number: NCT00513565
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder and Anxiety Disorders

Start date: 2007-09-13
Primary completion: 2009-05-14
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.